Chordoma CSCs quantified from cell culture using a CD24+CD133+ signature comprised <5% in all cell lines but one (Table 1), whereas CSCs appraised within imaged chordoma tumor samples using the CD15+CD24+ALDH+ signature comprised 1.39% of tumor cells (Table 2). The gene discussed is FUT4; the disease is neoplasm.